Zevra Therapeutics Advances Rare Disease Portfolio with New Data and Strategic Expansion
Zevra Therapeutics continues to build its profile as a dedicated rare disease company. Recent clinical data presentations and a broadening...
Zevra Therapeutics continues to build its profile as a dedicated rare disease company. Recent clinical data presentations and a broadening...
Conduent Inc. is navigating a critical period as it prepares to report annual results, with the severity of a recent...
Chemical manufacturer LSB Industries has issued a new round of equity-based compensation to its executive team, a move designed to...
Formerly known as Allscripts Healthcare, Veradigm Inc. is navigating a critical period of corporate realignment with a dual-focused approach that...
The Chinese fintech firm Yirendai is actively pursuing a strategic pivot, embedding advanced technologies like blockchain and artificial intelligence into...
Golden Entertainment is moving forward with plans to leave the public stock exchange, initiating a comprehensive privatization strategy. The company’s...
Deluxe Corporation is successfully shedding its legacy identity as a check-printing specialist. The company's strategic pivot toward becoming a comprehensive...
Akso Health Group has solidified its strategic shift into the healthcare industry with the launch of a major global program...
The recent foray by telehealth company Hims & Hers into the lucrative weight-loss medication sector has hit an early regulatory...
Vulcan Energy Resources has formally transitioned from project development to execution, marking a pivotal moment for Europe's battery materials supply...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com